Home › Therapeutic areas › Hematology › Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy

Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (1 companies)

Companies with an active program in Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
OMER	Omeros	HematologyNeurology+2 Rare	1	Approved	$1.22B	6